Gates Hoover is a Rheumatology/Immunology physician. OpenAlex indexes 7 publications with 580 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1955 W Main St
Salem, VA 241533109
Telephone
540-387-0441Provider last certified this registry record 24 Sept 2025.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genentech USA, Inc.Program year20251 payment
- CSL BehringProgram year20251 payment
- GlaxoSmithKline, LLC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
71.7%Corticosteroid32.4%Fluticasone Propionate40%Trelegy Ellipta27%Budesonide-Formoterol Fumarate7%Arnuity Ellipta5%Mometasone Furoate5%Qvar Redihaler4%Fluticasone Propionate Hfa4%Dulera3%Symbicort3%Breztri Aerosphere2%Part D<11 patientsLeukotriene Receptor Antagonist24.8%Montelukast Sodium100%Part D≥109 patients+ 5 more classes in this area
Metabolism & gastrointestinal
21.7%H2 blocker14.5%Famotidine100%Part D≥73 patientsProton pump inhibitor5.9%Pantoprazole Sodium47%Omeprazole42%Esomeprazole Magnesium11%Part D<11 patients+ 1 more class in this area
Dermatology
6.7%Interleukin-4 Receptor alpha Antagonist6%Dupixent Syringe60%Dupixent Pen40%Part D<11 patientsCorticosteroid0.7%Triamcinolone Acetonide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Assessment of Eosinophils, Viruses and IgE Antibody in Wheezing Infants and Children
International Archives of Allergy and Immunology
2009 - Salivary cotinine levels in children presenting with wheezing to an emergency department
Pediatric Pulmonology
2000 - Salivary cotinine levels in children presenting with wheezing to an emergency department
Pediatric Pulmonology
2000 - Rhinovirus and Respiratory Syncytial Virus in Wheezing Children Requiring Emergency Care: IgE and Eosinophil Analyses
American Journal of Respiratory and Critical Care Medicine
1999
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”